Burn Patients at Risk of Sepsis: Is PSP the Early Biomarker You Need?
CLICK HERE FOR FREE REGISTRATION
- 3 March 2026
- 17h00
- Online
How do you differentiate systemic inflammatory response from Sepsis in your Burn patients?
Your challenge is not “IF” to initiate a Sepsis bundle, but “WHEN”!
Discover how Pancreatic Stone Protein (PSP), an early sepsis biomarker, helps clinicians differentiate septic from non-septic patients.
Join us for a 60-minute Abionic Live Webinar
Burn Patients at Risk of Sepsis: Is PSP the Early Biomarker You Need?
📅 Tuesday, March 3, 2026
🕝 5:00 PM CET | 11 AM EST
Meet the speakers:
Dr. Holger Klein, Chief Physician Plastic Surgery and Hand Surgery,
Kantonsspital Aarau, Switzerland
Feras Almujalli, PhD student, King Saud University, Saudi Arabia
On behalf of Prof. Dr. Paul Harrison, Associate Professor of traumatic injury and burns, University of Birmingham, United Kingdom
Prof. Dr. Denis Ehrl, Medical Director, Department of Plastic, Reconstructive and Hand Surgery Center for Severe Burn Injuries, Nuremberg South Hospital, Germany
Why attend:
✓ Understand the clinical utility of PSP as an early sepsis biomarker
✓ Explore real-world applications of PSP in burn units
✓ Learn how PSP distinguishes septic from non-septic patients
✓ Ask your questions during a live Q&A with leading experts